Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

12.5%

1 terminated out of 8 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed with results

Key Signals

2 with results67% success

Data Visualizations

Phase Distribution

8Total

Not Applicable (5)

P 1 (1)

P 2 (1)

P 3 (1)

Trial Status

Not Yet Recruiting3

Completed2

Recruiting2

Terminated1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT05437588Not ApplicableRecruiting

Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents

NCT07012824Not ApplicableNot Yet RecruitingPrimary

Couple-Based Crisis Safety Planning

NCT06957704Phase 3Not Yet Recruiting

Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents

NCT06921226Not ApplicableNot Yet RecruitingPrimary

Exploratory Analysis of Interpersonal and Intrapersonal Psychological Processes Implied in Risk-taking and Suicidal Behaviors, in Adult and Adolescent At-risk

NCT04276779Not ApplicableTerminatedPrimary

Effects of Alcohol and Mood on Attention

NCT06366334Not ApplicableRecruiting

Study of IV Ketamine for Emergency Department Treatment of Adolescent Suicidal Ideation

NCT02974010Phase 2Completed

Sequential Therapy for the Treatment of Severe Bipolar Depression.

NCT01355848Phase 1CompletedPrimary

Improving Care Provided to Patients Treated in a Level 1 Trauma Center Post-suicide Attempt

Showing all 8 trials